EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer Risk in Barrett’s Esophagus: A Clinical Review

Ahmed Sam Beydoun iD, Kaleigh A Stabenau, Kenneth W Altman iD, Nikki Johnston

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076018 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ahmed Sam Beydoun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal adenocarcinoma (EAC) is rapidly increasing in incidence and is associated with a poor prognosis. Barrett’s esophagus (BE) is a known precursor of esophageal adenocarcinoma. This review aims to explore Barrett’s esophagus, esophageal adenocarcinoma, and the progression from the former to the latter. An overview of the definition, diagnosis, epidemiology, and risk factors for both entities are presented, with special attention being given to the areas of debate in the literature. The progression from Barrett’s esophagus to esophageal adenocarcinoma is reviewed and the relevant molecular pathways are discussed. The definition of Barrett’s esophagus remains debated and without international consensus. This, alongside other factors, has made establishing the true prevalence of Barrett’s esophagus challenging. The degree of dysplasia can be a histological challenge, but is necessary to guide clinical management. The progression of BE to EAC is likely driven by inflammatory pathways, pepsin exposure, upregulation of growth factor pathways, and mitochondrial changes. Surveillance is maintained through serial endoscopic evaluation, with shorter intervals recommended for high-risk features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsAdenocarcinomaHumansDisease ProgressionRisk Factors

Stichwörter der Autor:innen

Barrett’s esophagusRNA sequencingcanceresophageal adenocarcinomagastroesophageal reflux diseasemolecular pathways

Autor:innen und Institutionen

  • Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Department of Otolaryngology-Head & Neck Surgery, Geisinger Medical Center, Danville, PA 17822, USA.

ORCID-Profile: Ahmed Sam Beydoun, Kenneth W Altman

Zitieren

APA

Beydoun, A. S., Stabenau, K. A., Altman, K. W., & Johnston, N. (2023). Cancer Risk in Barrett’s Esophagus: A Clinical Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076018

Vancouver

Beydoun AS, Stabenau KA, Altman KW, Johnston N. Cancer Risk in Barrett’s Esophagus: A Clinical Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076018

BibTeX
@article{Beydoun2023,
  author = {Beydoun, Ahmed Sam and Stabenau, Kaleigh A and Altman, Kenneth W and Johnston, Nikki},
  title = {Cancer Risk in Barrett’s Esophagus: A Clinical Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076018}
}
Kostenlos starten →